Deutsche Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $517M | Sell |
5,710,284
-344,739
| -6% | -$28.9M | 0.15% | 132 |
|
|
2026
Q1 | $485M | Buy |
6,055,023
+476,227
| +9% | +$39.3M | 0.16% | 136 |
|
|
2025
Q4 | $476M | Sell |
5,578,796
-584,849
| -9% | -$48M | 0.15% | 130 |
|
|
2025
Q3 | $479M | Buy |
6,163,645
+149,822
| +2% | +$11.7M | 0.16% | 128 |
|
|
2025
Q2 | $470M | Sell |
6,013,823
-766,305
| -11% | -$57.2M | 0.17% | 120 |
|
|
2025
Q1 | $491M | Sell |
6,780,128
-123,074
| -2% | -$8.81M | 0.19% | 107 |
|
|
2024
Q4 | $511M | Buy |
6,903,202
+652,923
| +10% | +$45.7M | 0.2% | 102 |
|
|
2024
Q3 | $412M | Buy |
6,250,279
+2,549,409
| +69% | +$185M | 0.17% | 122 |
|
|
2024
Q2 | $342M | Buy |
3,700,870
+68,251
| +2% | +$6.04M | 0.15% | 135 |
|
|
2024
Q1 | $347M | Sell |
3,632,619
-232,083
| -6% | -$19.5M | 0.16% | 123 |
|
|
2023
Q4 | $295M | Buy |
3,864,702
+1,120,426
| +41% | +$78M | 0.15% | 139 |
|
|
2023
Q3 | $190M | Buy |
2,744,276
+807,502
| +42% | +$64.9M | 0.12% | 164 |
|
|
2023
Q2 | $183M | Buy |
1,936,774
+81,814
| +4% | +$7.11M | 0.1% | 201 |
|
|
2023
Q1 | $153M | Sell |
1,854,960
-1,471,516
| -44% | -$116M | 0.09% | 232 |
|
|
2022
Q4 | $248M | Buy |
3,326,476
+1,098,714
| +49% | +$84.7M | 0.14% | 150 |
|
|
2022
Q3 | $184M | Buy |
2,227,762
+75,643
| +4% | +$7.28M | 0.11% | 188 |
|
|
2022
Q2 | $205M | Buy |
2,152,119
+65,074
| +3% | +$6.74M | 0.11% | 169 |
|
|
2022
Q1 | $246M | Sell |
2,087,045
-148,418
| -7% | -$16.6M | 0.11% | 169 |
|
|
2021
Q4 | $290M | Buy |
2,235,463
+75,982
| +4% | +$8.86M | 0.13% | 159 |
|
|
2021
Q3 | $244M | Buy |
2,159,481
+67,112
| +3% | +$7.66M | 0.12% | 178 |
|
|
2021
Q2 | $217M | Buy |
2,092,369
+133,535
| +7% | +$12.6M | 0.11% | 193 |
|
|
2021
Q1 | $164M | Buy |
1,958,834
+228,097
| +13% | +$19.3M | 0.09% | 229 |
|
|
2020
Q4 | $158M | Buy |
1,730,737
+140,849
| +9% | +$11.7M | 0.1% | 206 |
|
|
2020
Q3 | $127M | Sell |
1,589,888
-140,908
| -8% | -$11M | 0.09% | 217 |
|
|
2020
Q2 | $120M | Buy |
1,730,796
+287,436
| +20% | +$20.4M | 0.09% | 215 |
|
|
2020
Q1 | $90.8M | Sell |
1,443,360
-250,458
| -15% | -$18.1M | 0.08% | 239 |
|
|
2019
Q4 | $132M | Sell |
1,693,818
-783,660
| -32% | -$61.2M | 0.09% | 242 |
|
|
2019
Q3 | $182M | Buy |
2,477,478
+861,480
| +53% | +$60.5M | 0.13% | 161 |
|
|
2019
Q2 | $99.5M | Sell |
1,615,998
-55,989
| -3% | -$3.39M | 0.06% | 347 |
|
|
2019
Q1 | $107M | Sell |
1,671,987
-70,416
| -4% | -$4.02M | 0.06% | 336 |
|
|
2018
Q4 | $89M | Buy |
1,742,403
+169,287
| +11% | +$8.57M | 0.06% | 323 |
|
|
2018
Q3 | $91.3M | Sell |
1,573,116
-229,320
| -13% | -$11.2M | 0.05% | 418 |
|
|
2018
Q2 | $87.5M | Sell |
1,802,436
-96,861
| -5% | -$4.52M | 0.04% | 443 |
|
|
2018
Q1 | $88.3M | Buy |
1,899,297
+381,159
| +25% | +$16.6M | 0.04% | 434 |
|
|
2017
Q4 | $57M | Sell |
1,518,138
-1,168,773
| -43% | -$42.9M | 0.04% | 490 |
|
|
2017
Q3 | $97.9M | Buy |
2,686,911
+855,555
| +47% | +$32.6M | 0.07% | 330 |
|
|
2017
Q2 | $72.2M | Sell |
1,831,356
-222,771
| -11% | -$8.13M | 0.05% | 412 |
|
|
2017
Q1 | $64.4M | Buy |
2,054,127
+591,852
| +40% | +$18.5M | 0.05% | 425 |
|
|
2016
Q4 | $45.7M | Buy |
1,462,275
+8,805
| +0.6% | +$285K | 0.04% | 520 |
|
|
2016
Q3 | $58.4M | Sell |
1,453,470
-1,724,130
| -54% | -$64.9M | 0.04% | 470 |
|
|
2016
Q2 | $106M | Buy |
3,177,600
+612,609
| +24% | +$21M | 0.07% | 303 |
|
|
2016
Q1 | $75.4M | Sell |
2,564,991
-250,464
| -9% | -$6.91M | 0.06% | 374 |
|
|
2015
Q4 | $74.1M | Buy |
2,815,455
+357,615
| +15% | +$9.29M | 0.05% | 396 |
|
|
2015
Q3 | $58.2M | Sell |
2,457,840
-391,476
| -14% | -$9.45M | 0.05% | 450 |
|
|
2015
Q2 | $67.6M | Sell |
2,849,316
-642,954
| -18% | -$14.5M | 0.04% | 455 |
|
|
2015
Q1 | $82.9M | Buy |
3,492,270
+591,120
| +20% | +$13.3M | 0.05% | 401 |
|
|
2014
Q4 | $61.6M | Buy |
2,901,150
+592,854
| +26% | +$11.9M | 0.04% | 508 |
|
|
2014
Q3 | $39.3M | Buy |
2,308,296
+210,042
| +10% | +$3.32M | 0.02% | 637 |
|
|
2014
Q2 | $30M | Sell |
2,098,254
-569,364
| -21% | -$7.72M | 0.02% | 728 |
|
|
2014
Q1 | $33M | Sell |
2,667,618
-1,122,582
| -30% | -$13M | 0.02% | 680 |
|
|
2013
Q4 | $41.5M | Sell |
3,790,200
-1,199,028
| -24% | -$13.5M | 0.03% | 567 |
|
|
2013
Q3 | $57.9M | Buy |
4,989,228
+242,946
| +5% | +$2.84M | 0.04% | 448 |
|
|
2013
Q2 | $53.1M | Buy |
+4,746,282
| New | +$56.2M | 0.04% | 444 |
|
Other funds holding EW
Deutsche Bank's EW Position: Q2 2026 in Review
Deutsche Bank reduced its Edwards Lifesciences (EW) stake by 5.7% in Q2 2026, selling an estimated $28.9M and leaving 5,710,284 shares worth $517M. The position accounts for 0.15% of the portfolio, ranked #132.
Deutsche Bank first reported a position in EW in Q2 2013 and has held it in 53 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Deutsche Bank held 5,710,284 shares of Edwards Lifesciences worth $517M as of Q2 2026.
- Deutsche Bank sold 344,739 Edwards Lifesciences shares in Q2 2026, an estimated $28.9M.
- Edwards Lifesciences made up 0.15% of Deutsche Bank's portfolio in Q2 2026, its #132 holding.
- Deutsche Bank first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.